All posts tagged
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best
Investors Jump on Hypersensitivity Peptides from GSK Spinout
A French Biotech has put a new Lyme Disease Vaccine on the Horizon
Career in Sight! Set sail for Novartis, GSK or Shire!
UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa
UPDATE: GSK is staging a comeback with a new Shingles Vaccine
Another Brexit Siren Sounds: GSK’s CEO weighs in on the EMA’s (Re)Location
Results from 45% of Clinical Trials are kept Secret
Boehringer buys a €210M ticket to Virus-based Immuno-Oncology
GSK appoints First Woman CEO of Global Drug Maker
Labiotech UG, All Rights Reserved -
Send this to friend